TotalMarketCap

Revelation Biosciences

REVBNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.026 M

$3.56 -8.60%

Close of 6 Nov 2026

As of 6 Nov 2026, Revelation Biosciences (REVB) has a market capitalization of $2.03M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$8.91M

Loss-making

Shares outstanding

683,442

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Revelation Biosciences lists more than one class of stock. Company figures above cover all classes combined.

REVBW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #480HCW BiologicsHCWB$2.30M
  2. #481Sunshine BiopharmaSBFM$2.16M
  3. #482Revelation BiosciencesREVB$2.03M
  4. #483Purple BiotechPPBT$2.02M
  5. #484GeoVax LabsGOVX$1.95M

What if Revelation Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$49,620,293

Per share 13,938,285× higher

Bitcoin $1.53T

$2,684,868

Per share 754,176× higher

Apple $5.02T

$8,814,170

Per share 2,475,890× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Revelation Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.